Keystone Symposia – 2025 – Poster Presentation 2033 […]
Publication Programs: Discovery Platform
Multimodal atlas of paired diagnosis and relapse AML reveals surface antigens for multi-specific immunotherapy
ASH – 2024 – Poster Presentation 1558 […]
Leveraging CRISPR/Cas9 and HDR to create an engineered CD33 CAR-T to treat AML
SITC – 2024 – Poster Presentation 1092 […]
Read More… from Leveraging CRISPR/Cas9 and HDR to create an engineered CD33 CAR-T to treat AML
Analyzing Guide RNA (gRNA) Impurity Discovery & Quantification
CRISPR-Based Therapy Analytical Development Summit – Oral Presentation […]
Read More… from Analyzing Guide RNA (gRNA) Impurity Discovery & Quantification
Purification of CAR+ T Cells Reveals Impact of Untransduced Cells in CAR-T Drug Product
Immuno-Oncology Summit – 2024 – Poster Presentation P26 […]
Gene-Edited Hematopoietic Stem Cells to Enable Next-Generation CAR-T Cell Therapy for the Treatment of AML
ASGCT – 2024 – Poster Presentation 1775 […]
Uncovering Molecular and Functional Dynamics of Human Hematopoietic Stem Cells during In Vitro Culture for Cell Therapy Manufacturing
Keystone Symposia – 2024 – Poster Presentation 1040 […]
Leveraging CRISPR/Cas9 and HDR to create an engineered CD33 CAR-T to target AML
Keystone Symposia – 2024 – Poster Presentation 2538 […]
Read More… from Leveraging CRISPR/Cas9 and HDR to create an engineered CD33 CAR-T to target AML